CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT Short-Term Progression of Multiterritorial Subclinical Atherosclerosis When, where, and how to target vascular inflammation in the post-CANTOS era? Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures 2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee Coronary calcification in the diagnosis of coronary artery disease

Original ResearchVolume 73, Issue 22, June 2019

JOURNAL:J Am Coll Cardiol. Article Link

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

DL Bhatt, G Steg, and on behalf of the REDUCE-IT Investigators. Keywords: eicosapentaenoic acid; icosapent ethyl; statin; time-to-first-event;

FULL TEXT PDF